BioMark Diagnostics Inc. (BMKDF)

USD 0.15

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 163.22 Thousand 153.49 Thousand 43.93 Thousand - 263.28 Thousand -
Cost of Revenue 393.17 Thousand 386.19 Thousand - 13.68 Thousand - -
Gross Profit -229.95 Thousand -232.7 Thousand 43.93 Thousand -13.68 Thousand 263.28 Thousand -
Operating Expenses 163.22 Thousand 1.88 Million 1.44 Million 1.08 Million 1.47 Million 545.61 Thousand
Selling, General and Administrative Expenses 926.22 Thousand 1.15 Million 863.85 Thousand 961.47 Thousand 1.41 Million 489.18 Thousand
Research and Development Expenses 650.53 Thousand 545.84 Thousand 497.77 Thousand 118.43 Thousand 42.34 Thousand 56.43 Thousand
Other Expenses - - - - - -
Cost and Expenses 1.47 Million 1.88 Million 1.44 Million 1.08 Million 1.47 Million 545.61 Thousand
Operating Income -1.31 Million -1.73 Million -1.4 Million -1.08 Million -1.2 Million -545.61 Thousand
Interest Expense 115.16 Thousand 110.23 Thousand 49.68 Thousand 4138.00 2392.00 -
Income Tax Expense - - 49.68 Thousand 4138.00 6237.00 -526.86 Thousand
Earnings before Tax -1.42 Million -1.84 Million -1.45 Million -1.09 Million -1.21 Million -545.61 Thousand
Net Income -1.42 Million -1.84 Million -1.45 Million -1.09 Million -1.21 Million -545.61 Thousand
Earnings Per Share Basic -0.02 -0.02 -0.02 -0.01 -0.02 -0.01
Earnings Per Share Diluted -0.02 -0.02 -0.02 -0.01 -0.02 -0.01
Weighted Average Shares Outstanding 85.23 Million 82.77 Million 72.31 Million 73.3 Million 71.29 Million 65.91 Million
Weighted Average Shares Outstanding (Diluted) 85.23 Million 82.77 Million 72.31 Million 73.3 Million 71.29 Million 65.91 Million
Gross Margin -1.41 -1.52 1.00 - 1.00 -
EBIT Margin -5.63 -8.77 -27.85 - -4.52 -
Profit Margin -8.75 -12.00 -33.09 - -4.62 -
EBITDA -919.04 Thousand -1.34 Million -1.22 Million -1.02 Million -1.19 Million -545.61 Thousand
Earnings Before Tax Margin -8.06 -11.28 -31.94 - -4.57 -

Income Statement Charts